Skip to main content

Sangrix Inc.

SGRX
Exchange
Nasdaq
Industry
Finance Services
SEC CIK
0001735556

No open-market purchases or sales by Sangrix Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Holders of 5% or more of SGRX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Sangrix Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of SGRX
HolderLatest formStakeChangeFirst filedLatest filingFiling
Jiang Jinghai13D9.00%768.0K sharesNewFeb 10, 20251 filingFeb 10, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

2 Schedule 13D and 13G filings on Sangrix Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on SGRX
Filed (ET)FilerFormStakeChangeEvent dateFiling
Feb 10, 20255:59 PM ETJiang Jinghai13D9.00%768.0K sharesNewFeb 2, 2025SEC
Feb 16, 2021Dai Zeshu13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Sangrix Inc. shares.

No Form 144 notices for Sangrix Inc. are on file.